Cardiac Safety Profile of Caelyx Therapy in Anthracyclin Pretreated Metastatic Breast Cancer Patients.

Trial Profile

Cardiac Safety Profile of Caelyx Therapy in Anthracyclin Pretreated Metastatic Breast Cancer Patients.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 05 Nov 2013

At a glance

  • Drugs Doxorubicin liposomal (Primary)
  • Indications Advanced breast cancer
  • Focus Adverse reactions
  • Sponsors Schering-Plough
  • Most Recent Events

    • 06 Nov 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top